网站主页 >> CAS数据库列表 >> N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea
N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea
|
|
- CAS号:
- 133825-80-6
- 英文名:
- N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea
- 英文别名:
- ATR-101;PD-132301;ATR 101; ATR101; PD-132301;1-(2,6-Diisopropylphenyl)-3-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea;N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea;Urea, N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-
- 中文名:
- N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea
- 中文别名:
- 化合物 T12225;1-(2,6-二异丙基苯基)-3-((1-(4-二甲胺基)苯基)环戊基)甲基)脲
- CBNumber:
- CB31327866
- 分子式:
- C27H39N3O
- 分子量:
- 421.62
- MOL File:
- 133825-80-6.mol
|
|
|
N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea化学性质
-
沸点:
-
528.1±50.0 °C(Predicted)
-
|
-
密度:
-
1.062±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
2-8°C
-
|
-
酸度系数(pKa):
-
13.91±0.46(Predicted)
-
|
N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea性质、用途与生产工艺
Nevanimibe (PD-132301) 是一种口服有效的,选择性酰基辅酶 A:胆固醇 O-酰基转移酶 1 (ACAT1) 抑制剂,EC50 为 9 nM。Nevanimibe 抑制 ACAT2,EC50 为 368 nM。Nevanimibe 诱导细胞凋亡 (apoptosis),并具有抗肾上腺皮质癌的潜力。
ACAT1
9 nM (EC
50
)
|
ACAT2
368 nM (EC
50
)
|
Coincubation of Nevanimibe (PD-132301; ATR101; 3 nM-30 μM) and Cholesterol markedly increases toxicity in a dose-dependent manner, where 3 nM Nevanimibe in the presence of 60 μg/mL Cholesterol reduces survival by 60% after 24 hours. All doses of Nevanimibe (3 nM-30 μM) induces cytoxicity in the presence of Cholesterol, whereas treatment with Cholesterol in the absence of Nevanimibe has no effect on cell viability.
Cell Cytotoxicity Assay
Cell Line:
|
The H295R and HAC clone 15 (HAC15) human ACC cell lines
|
Concentration:
|
3 nM-30 μM
|
Incubation Time:
|
24 hours
|
Result:
|
3 nM-3 μM exhibited no toxicity, whereas 30 μM treatment reduced survival by approximately 40% within 24 hours.
|
N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea
上下游产品信息
上游原料
下游产品
N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea
生产厂家
133825-80-6, N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea 相关搜索:
- 化合物 T12225
- 1-(2,6-二异丙基苯基)-3-((1-(4-二甲胺基)苯基)环戊基)甲基)脲
- 133825-80-6
- ATR 101; ATR101; PD-132301
- PD-132301
- Urea, N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-
- 1-(2,6-Diisopropylphenyl)-3-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea
- ATR-101
- N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea